| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
Celldex Therapeutics, Inc. (CLDX) has 19 insiders with recent SEC Form 4 filings, including 0 buys and 18 sells. CLDX is classified in the Biotechnology industry within the Health Care sector.
| Role | Insider | Shares | Value | 30d |
|---|---|---|---|---|
| CEO | 300.0K | $10.19M | - | |
| VP | 100.0K | $3.40M | - | |
| VP | 93.0K | $3.16M | - | |
| VP | 85.0K | $2.89M | - | |
| VP | 82.0K | $2.79M | - |
Buys and sells only
| Date | Insider | Role | Type | Shares | Price | Value | Chg% | 3M | 12M | SEC |
|---|---|---|---|---|---|---|---|---|---|---|
| Aug 12, 2022 | Martin Samuel Bates67 | SVP And CFO | Sale+OE | 20,000 | $36.52 | $730,485.09 | -16.4% | +1.3% | -19.0% | |
| Dec 23, 2021 | Martin Samuel Bates67 | SVP And CFO | Sale+OE | 9,500 | $42.00 | $399,000.00 | -28.0% | -19.5% | +5.0% | |
| Dec 8, 2021 | Cavanaugh Sarah66 | SVP Of Corp Affairs &Admin. | Sale+OE | 7,323 | $40.00 | $292,920.00 | -94.7% | -28.0% | -2.3% | |
| Dec 8, 2021 | Crowley Elizabeth64 | Sr. VP &Cpdo | Sale+OE | 4,000 | $40.00 | $160,000.00 | -45.8% | -28.0% | -2.3% | |
| Dec 8, 2021 | Heath-Chiozzi Margo65 | SVP Of Regulatory Affairs | Sale+OE | 600 | $40.00 | $24,000.00 | -5.1% | -28.0% | -2.3% | |
| Nov 15, 2021 | Martin Samuel Bates67 | SVP And CFO | Sale+OE | 9,500 | $43.57 | $413,883.36 | -14.5% | -26.4% | -14.7% | |
| Nov 12, 2021 | Young Diane C.63 | SVP, Chief Medical Officer | Sale+OE | 4,600 | $42.94 | $197,529.06 | -68.5% | -24.3% | -10.2% | |
| Nov 1, 2021 | Cavanaugh Sarah66 | SVP Of Corp Affairs &Admin. | Sale+OE | 7,323 | $43.26 | $316,804.37 | -53.5% | -29.7% | -19.8% | |
| Nov 1, 2021 | Crowley Elizabeth64 | Sr. VP &Cpdo | Sale+OE | 4,317 | $43.29 | $186,874.47 | -20.1% | -29.7% | -19.8% | |
| Nov 1, 2021 | Heath-Chiozzi Margo65 | SVP Of Regulatory Affairs | Sale+OE | 600 | $41.71 | $25,026.00 | -5.1% | -29.7% | -19.8% |